Pro-Dex Inc (PDEX)

Healthcare Medical Instruments & Supplies

58.60 $

+3.4% vs. previous close

Closing price · As of: 31. Jul 2026

Add to watchlist

Stock Watch

Stock Watch will tell you what changes at Pro-Dex Inc.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 6 of our scanner strategies — each hit links to the scanner.

Quality & Balance Sheet

Altman Z: Balance Sheet Fortress

Momentum & Trend

21-EMA Trend High ADR (≥5%) Mark Minervini: Trend Criteria — 1 Month Stan Weinstein: Stage 2

Risk & Weakness

Beneish M-Score

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Basics

Market Cap

0.2$B

Shares Outstanding

3Mio.

Float

54.8%

Beta

0.02

Performance

Perf. 1M

-13.50%

Perf. 3M

19.20%

Perf. 6M

44.50%

YTD Performance (%)

64.70%

52-Week-High Distance

-5.3%

Perf. 1Y

54.76%

Perf. 3Y

231.00%

Perf. 5Y

120.81%

Valuation

P/E

15.2

Forward P/E

22.3

PEG

–

P/B

3.8

P/S

2.5

EV/EBITDA

11.4

Price/FCF

27.0

Profitability

Gross Margin

27.8%

EBIT Margin

–

Net Margin

16.1%

Return on Equity

29.8%

Return on Assets

9.7%

Balance Sheet & Safety

Equity Ratio

–

Debt/Equity

0.4

fortress balance sheet

Altman Z″

11.78

Piotroski

7 out of 9

Growth

Sales Growth Last Quarter

14.60%

EPS Growth Last Quarter

22.40%

Sales Growth (Year)

23.68%

Forward Sales Growth

6.02%

Forward EPS Growth

–

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage

RS Rating

EPS Rating

Piotroski

7 out of 9

Fundamental Rating

B (69 out of 100)

fortress balance sheet

Altman Z″

11.78

AI Rating

–

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 58.60 $

Price Target (average) 70.00 $

The price target sits 19.5% above the current price.

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Next Reporting Date

3. Sep 2026 · Q2 2026

Expected Earnings per Share: 0.67 $

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Sales Per Quarter ($M)

Earnings Per Share Per Quarter ($)

Net Margin Per Quarter (%)

Operating Cash Flow Per Quarter ($M)

Free Cash Flow Per Quarter ($M)

Sales Growth vs. Year-Ago Quarter (%)

EPS Growth vs. Year-Ago Quarter (%)

Price Change in Quarter (%)

Quarterly Figures

Quarterly Figures
Quarter	EPS (Earnings Per Share)	EPS YoY (%)	Sales ($M)	Sales YoY (%)	Net Margin (%)	OCF ($M)	FCF ($M)
2024: Q4	0.64	308.00	17	33.40	12.10	-4	-5
2025: Q1	1.03	400.00	17	21.80	18.80	1	1
2025: Q2	0.37	-24.60	18	16.40	6.80	0	0
2025: Q3	1.47	89.80	19	24.40	25.30	2	2
2025: Q4	0.68	7.20	19	11.10	11.70	4	4
2026: Q1	1.23	20.20	20	14.60	19.70	2	2

What Do These Terms Mean?

EPS (Earnings Per Share):: Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):: Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:: All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:: What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):: The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):: Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

About the Company

Pro-Dex, Inc. entwirft, entwickelt, fertigt und verkauft motorisierte chirurgische Instrumente für Medizinprodukte-Erstausrüster weltweit.

Employees	179
Headquarters	Irvine, CA
Website	pro-dex.com
IPO Date	18. Aug 1995

Management

Management
Name	Title	Birth Year
Richard Lee Van Kirk Jr.	CEO, President, COO & Director	1961
Alisha K. Charlton	CFO & Corporate Secretary	1970

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date	Person	Role	Type	Shares	Price	Value
16. Mar 2026	Domingo Angelita Rebamontan	Director	Sell	998	47.24	47,146

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.